WASHINGTON, DC—The American Pharmacists Association (APhA) has selected four recipients of its 2024 Impacting Immunization Implementation Through Quality Improvement Grant, recognizing pharmacy residents who have developed continuous quality improvement (CQI) projects designed to positively impact immunization processes at pharmacy practice sites across the country.

WASHINGTON, DC— Today the American Pharmacists Association (APhA) and the National Alliance of State Pharmacy Associations (NASPA) released the tenth installment of the Pharmacy Workplace and Well-being Reporting (PWWR) trends and learnings report series.

WASHINGTON, DC – Today, the American Pharmacists Association (APhA) announced the start of a new consumer-focused campaign to end the harmful practices of pharmacy benefit managers (PBMs). 

WASHINGTON, DC – A coalition of organizations representing pharmacies and pharmacists across all practice settings released a statement today ahead of a Tuesday, July 23 U.S. House Committee on Oversight and Accountability hearing titled, “The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part III: Transparency and Accountability.”

WASHINGTON, DC—The American Pharmacists Association (APhA) is concerned with the recent decision by the United States Court of Appeals for the Fifth Circuit in Braidwood Mgmt v. Becerra, which may weaken current requirements for insurers to cover preventative care services and medications.